ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Sonde Health, in Collaboration with KT Corporation, to Provide Voice-Based Mental Health Monitoring Services to Help South Korea Tackle Mental Health Issues

Sonde Health and KT Corporation (KT) have agreed to collaborate on a next-generation mental health management solution.

Sonde Health will provide its clinically validated Mental Fitness vocal biomarker solution to screen users’ mental health on a daily basis. Meanwhile, KT Corporation, South Korea's largest telecommunications service provider, will offer the infrastructure and relevant services to help users improve their mental health.

Over the next few years, Sonde will work closely with KT to develop and deliver technologies using Sonde’s Mental Fitness solution, to expand access and support for mental health services for many segments of the population.

“Our voices are an early indicator of our mental fitness and, when tracked, can provide awareness that can spur behavior change in order to stay healthy,” said David Liu, CEO of Sonde Health. “Through this collaboration with KT, our vocal biomarker solution will give South Koreans insight into their mental health so they can be proactive in maintaining their well-being.”

According to Team Leader Mr. M. G. Kwak from KT's Healthcare Business Team, “KT is developing a digital platform to provide mental health wellness services to many segments of the population across Korea. Sonde Health will join KT’s initiative by integrating its voice-based mental health solutions into KT’s platform.”

Sonde Mental Fitness leverages audio signal processing, speech science, and machine learning (ML) algorithms trained on more than a million global voice samples to optimize its performance across cultures, languages, and socioeconomic groups. Using a 30-second voice sample, the technology analyzes eight acoustic features relevant to mental health and delivers a score divided into three ranges: “Pay Attention” (0-69), “Good” (70-79), and “Excellent" (80-100).

In a recent published study, Sonde Mental Fitness was found to accurately identify individuals with mental health symptoms, delivering results consistent with those of the M3 Checklist, a clinically validated, mental health assessment for depression, anxiety disorder, post-traumatic stress disorder (PTSD), and bipolar disorder.

This partnership is part of a broader strategy to accelerate global adoption of Sonde Mental Fitness. Sonde’s vocal biomarker solution is already deployed by life insurers, pharmaceutical companies, wellness providers, and military organizations in the U.S. and abroad.

About Sonde Health

Sonde Health is the global leader in voice-based health tracking and data insights. Sonde’s vocal biomarker API/SDK serves enterprise apps and devices spanning consumer wellness to population health. Leveraging a best-in-class voice data set and clinical research with over 1.2 million samples from 85,000+ individuals on four continents, Sonde uses advanced audio signal processing, speech science, and AI/machine learning to sense and analyze subtle vocal changes due to changes in a person’s physiology to provide key insights into health and well-being.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.67
+4.26 (1.74%)
AAPL  269.63
+1.16 (0.43%)
AMD  246.23
+12.69 (5.43%)
BAC  53.70
+0.50 (0.95%)
GOOG  290.20
+10.50 (3.75%)
META  634.21
+12.50 (2.01%)
MSFT  505.35
+8.53 (1.72%)
NVDA  197.18
+9.03 (4.80%)
ORCL  238.78
-0.48 (-0.20%)
TSLA  445.61
+16.09 (3.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.